Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV

The advent of direct-acting antiviral (DAA) therapies has dramatically transformed HCV treatment, with most recent trials demonstrating high efficacy rates (>90%) across all genotypes and special populations, including patients with HIV/HCV coinfection. The efficacy rates of HCV treatment are nea...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Sonia Vibhakar, Jayaweera, Dushyantha T., Althoff, Keri N., Eron, Joseph J., Radtchenko, Janna, Mills, Anthony, Moyle, Graeme, Santiago, Steven, Sax, Paul E., Gillman, Jason, Mounzer, Karam, Elion, Richard A., Huhn, Gregory D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018045/
https://www.ncbi.nlm.nih.gov/pubmed/32053682
http://dx.doi.org/10.1371/journal.pone.0228847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018045/
https://www.ncbi.nlm.nih.gov/pubmed/32053682
http://dx.doi.org/10.1371/journal.pone.0228847

Ejemplares similares